1. Home
  2. GKOS vs CFLT Comparison

GKOS vs CFLT Comparison

Compare GKOS & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CFLT
  • Stock Information
  • Founded
  • GKOS 1998
  • CFLT 2014
  • Country
  • GKOS United States
  • CFLT United States
  • Employees
  • GKOS N/A
  • CFLT N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CFLT EDP Services
  • Sector
  • GKOS Health Care
  • CFLT Technology
  • Exchange
  • GKOS Nasdaq
  • CFLT Nasdaq
  • Market Cap
  • GKOS 5.8B
  • CFLT 5.9B
  • IPO Year
  • GKOS 2015
  • CFLT 2021
  • Fundamental
  • Price
  • GKOS $94.00
  • CFLT $19.29
  • Analyst Decision
  • GKOS Strong Buy
  • CFLT Buy
  • Analyst Count
  • GKOS 12
  • CFLT 30
  • Target Price
  • GKOS $131.17
  • CFLT $29.13
  • AVG Volume (30 Days)
  • GKOS 693.4K
  • CFLT 9.0M
  • Earning Date
  • GKOS 11-03-2025
  • CFLT 10-29-2025
  • Dividend Yield
  • GKOS N/A
  • CFLT N/A
  • EPS Growth
  • GKOS N/A
  • CFLT N/A
  • EPS
  • GKOS N/A
  • CFLT N/A
  • Revenue
  • GKOS $432,953,000.00
  • CFLT $1,064,824,000.00
  • Revenue This Year
  • GKOS $28.79
  • CFLT $21.83
  • Revenue Next Year
  • GKOS $25.65
  • CFLT $16.44
  • P/E Ratio
  • GKOS N/A
  • CFLT N/A
  • Revenue Growth
  • GKOS 26.70
  • CFLT 23.02
  • 52 Week Low
  • GKOS $77.10
  • CFLT $15.64
  • 52 Week High
  • GKOS $163.71
  • CFLT $37.90
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.08
  • CFLT 49.84
  • Support Level
  • GKOS $89.83
  • CFLT $18.34
  • Resistance Level
  • GKOS $97.00
  • CFLT $20.28
  • Average True Range (ATR)
  • GKOS 2.65
  • CFLT 0.65
  • MACD
  • GKOS 0.39
  • CFLT 0.40
  • Stochastic Oscillator
  • GKOS 71.27
  • CFLT 71.73

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

Share on Social Networks: